journal article·2024-01Open access

Fine‐tuning Dynamic Cross–linking for Enhanced 3D Bioprinting of Hyaluronic Acid Hydrogels

Shima Tavakoli, Nithiyanandan Krishnan, Hamidreza Mokhtari, Oommen P. Oommen, Oommen P. Varghese

Advanced Functional Materials· Volume 34· Issue 4

Abstract

Abstract 3D bioprinting of stem cells shows promise for medical applications, but the development of an efficient bioink remains a challenge. Recently, the emergence of dynamically cross–linked hydrogels has advanced this field to obtain self‐healing materials. However, more advanced bioinks are needed that display optimum gelling kinetics, viscoelasticity, shear‐thinning property, structural fidelity, and hold the printed structures sufficiently long enough that allow maturation of the new tissue. Here, a novel extracellular matrix‐based bioink for human mesenchymal stem cells (hMSCs) is presented. Hyaluronic acid (HA) is modified with cysteine and aldehyde functional groups, creating hydrogels with dual cross–linking of disulfide and thiazolidine products. The investigation demonstrates that this cross–linking significantly improves hydrogel stability and biological properties. The bioink exhibits fast gelation kinetics, shear‐thinning, shape‐maintaining properties, high cell survival after printing with >2‐fold increase in stemness marker (OCT3/4 and NANOG), and supports cell proliferation and migration. Disulfide cross–linking contributes to self‐healing and cell migration, while thiazolidine cross–linking reduces gelation time, enhances long‐term stability, and supports cell proliferation. Overall, the HA‐based bioink fulfills the requirements for successful 3D printing of stem cells, providing a promising solution for cell therapy and regenerative medicine.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Cellular Mechanics and Interactions · Cell Image Analysis Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Translational Chemical Biology Laboratory Division of Macromolecular Chemistry Department of Chemistry‐Ångstrom Laboratory Uppsala University Uppsala SE75121 Sweden

Bioengineering and Nanomedicine Group Faculty of Medicine and Health Technologies Tampere University and BioMediTech Institute Tampere 33720 Finland

Funding

Vinnova · Eurostars · Vetenskapsrådet · H2020 Marie Skłodowska-Curie Actions

References (52)

Show source-provided references
1. 10.1007/s40898-017-0003-810.1007/s40898-017-0003-8 ↗
2. 10.1038/nbt.295810.1038/nbt.2958 ↗
3. 10.3390/gels810060910.3390/gels8100609 ↗
4. 10.3390/mi1307103810.3390/mi13071038 ↗
5. 10.1021/acs.chemmater.2c0203710.1021/acs.chemmater.2c02037 ↗
6. 10.15252/embr.20205002810.15252/embr.202050028 ↗
7. 10.1088/1758-5090/acab3410.1088/1758-5090/acab34 ↗
8. 10.1038/aps.2013.5010.1038/aps.2013.50 ↗
9. 10.1007/s12195-018-0530-210.1007/s12195-018-0530-2 ↗
10. 10.1007/s40778-016-0058-010.1007/s40778-016-0058-0 ↗
11. Rangasami V. K. · Biomacromolecules · 1980 · 22 · 2021
12. 10.1016/j.bioadv.2023.21333110.1016/j.bioadv.2023.213331 ↗
13. 10.1039/C9TB00485H10.1039/C9TB00485H ↗
14. 10.1039/D2BM01154A10.1039/D2BM01154A ↗
15. 10.1016/j.ijbiomac.2021.08.14010.1016/j.ijbiomac.2021.08.140 ↗
16. 10.1016/j.biomaterials.2019.11951610.1016/j.biomaterials.2019.119516 ↗
17. Paidikondala M. · ACS Appl. Bio Mater. · 2006 · 2 · 2019
18. 10.1016/j.biomaterials.2018.01.04110.1016/j.biomaterials.2018.01.041 ↗
19. 10.1002/adhm.20190179810.1002/adhm.201901798 ↗
20. 10.1002/jbm.a.3632310.1002/jbm.a.36323 ↗
21. 10.1002/adfm.20120169810.1002/adfm.201201698 ↗
22. 10.1126/sciadv.ade788010.1126/sciadv.ade7880 ↗
23. 10.1186/s41038-018-0138-810.1186/s41038-018-0138-8 ↗
24. 10.1016/j.colsurfb.2016.01.00810.1016/j.colsurfb.2016.01.008 ↗
25. 10.1016/j.biomaterials.2015.11.01810.1016/j.biomaterials.2015.11.018 ↗
26. 10.3390/gels403007210.3390/gels4030072 ↗
27. 10.1021/acs.biomac.8b0183010.1021/acs.biomac.8b01830 ↗
28. 10.1039/C8CC05405C10.1039/C8CC05405C ↗
29. 10.1021/bm400612h10.1021/bm400612h ↗
30. 10.1038/s42004-019-0224-210.1038/s42004-019-0224-2 ↗
31. 10.1016/j.carbpol.2023.12110310.1016/j.carbpol.2023.121103 ↗
32. 10.1021/bc060060f10.1021/bc060060f ↗
33. 10.1039/C9PY00862D10.1039/C9PY00862D ↗
34. 10.1039/C1SM06513K10.1039/C1SM06513K ↗
35. 10.1016/j.eurpolymj.2020.11002410.1016/j.eurpolymj.2020.110024 ↗
36. 10.1021/bc970109510.1021/bc9701095 ↗
37. 10.1021/acs.macromol.2c0171410.1021/acs.macromol.2c01714 ↗
38. 10.1089/ten.teb.2007.033210.1089/ten.teb.2007.0332 ↗
39. 10.1038/sj.embor.740064510.1038/sj.embor.7400645 ↗
40. 10.1021/acsami.9b1023910.1021/acsami.9b10239 ↗
41. 10.1002/jbm.a.3684710.1002/jbm.a.36847 ↗
42. 10.1016/j.mtbio.2022.10053710.1016/j.mtbio.2022.100537 ↗
43. 10.1038/nmat201310.1038/nmat2013 ↗
44. 10.1016/S1534-5807(04)00075-910.1016/S1534-5807(04)00075-9 ↗
45. 10.1016/j.actbio.2013.07.02510.1016/j.actbio.2013.07.025 ↗
46. 10.1182/blood.V90.6.221710.1182/blood.V90.6.2217 ↗
47. 10.3727/096368916X69333810.3727/096368916X693338 ↗
48. 10.1016/j.biomaterials.2021.12121610.1016/j.biomaterials.2021.121216 ↗
49. 10.3389/fbioe.2022.86577010.3389/fbioe.2022.865770 ↗
50. 10.1002/adhm.20200205810.1002/adhm.202002058 ↗
51. 10.1038/s41598-017-01528-310.1038/s41598-017-01528-3 ↗
52. Aitken A. · Cold Spring Harb. Protoc. · 2008 · 3 · 1053